Udvalget for Humanmedicinske Lægemidler (CHMP) konkluderede, at vildagliptin taget sammen med metformin sænker blodsukkeret, og kombinationen af de to aktive stoffer i én tablet gør det lettere for patienterne at overholde behandlingen.
The Committee for Medicinal Products for Human Use (CHMP) concluded that vildagliptin taken with metformin reduces blood glucose levels and the combination of the two active substances in one tablet may help patients to stick to their treatment.